Clinical Trial Update: Comparison of ATG to Thymoglobuline in Renal Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing antithymocyte globulin (ATG) to Thymoglobulin in kidney transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• ATG (anti-thymocyte globulin)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Transplantation, Kidney | Phase 4 | Status: COMPLETED